At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 70 enrolled
Drug / intervention
Aminolevulinic Acid PDT (ALA) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Photodynamic Therapy (PDT)With LEVULAN® Topical Solution + Blue Light Versus LEVULAN® Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities
In Brief
A Phase 2 clinical trial evaluating Aminolevulinic Acid PDT (ALA) and Vehicle PDT (VEH) for Keratosis, Actinic. Completed, enrolled 70 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKeratosis, Actinic
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 2011
Enrollment StartNov 2011
Primary CompletionJul 2012
TodayJul 2026
First PostedOct 25, 2011
Enrollment StartNov 1, 2011
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.7 years ago
Interventions
Aminolevulinic Acid PDT (ALA)drug
20% ALA applied to upper extremities for 3 hours prior to 10 J/cm2 blue light
Vehicle PDT (VEH)drug
Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to upper extremities 3 hours prior to 10 J/cm2 blue light